<?xml version="1.0" encoding="UTF-8"?>
<p>The antiviral effects of IFNs are expressed through activating interferon-stimulated genes (ISGs) (
 <xref rid="B14" ref-type="bibr">14</xref>). Additionally, by decreasing the vascular leakage, IFN Î²-1a improved ARDS complications, regardless of its antiviral properties (
 <xref rid="B15" ref-type="bibr">15</xref>). The higher expression of a protein named CD-73 also could lead to a better prognosis in ARDS. However, these data were not replicated in a later trial (
 <xref rid="B16" ref-type="bibr">16</xref>).
</p>
